🔎 Trials Near Me

Akèy › Kansè orofaringe › Illinois › Chicago

Etid klinik pou Kansè orofaringe nan Chicago, IL

7 etid pou Kansè orofaringe ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

Ap rekriteFaz 2
  • Rush MD Anderson Cancer Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT07195734

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Ap rekriteFaz 2
  • Northwestern University, Chicago
  • University of Illinois, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05136196

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

Ap rekriteFaz 1
  • Northwestern University, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT05172245

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Ap rekriteFaz 2
  • Northwestern University, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT06532279

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

Ap rekriteFaz 3
  • Northwestern University, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07441681

Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial

Ap rekriteFaz 2
  • Northwestern University, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT07178301

Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer

Ap rekriteFaz 2
  • The University of Chicago Medicine Comprehensive Cancer Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Feb 6, 2026 · NCT07290621

Etid Kansè orofaringe nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.